News

News On 622m
Tulsa stroke survivors invited to check out new FDA approved therapy process
The PAM Health Rehabilitation of Tulsa held free mini screenings to show stroke survivors a new FDA-approved rehabilitation ...
Fierce Pharma41m
AbbVie advances solid tumor agenda with FDA nod for lung cancer ADC Emrelis
After flexing its antibody-drug conjugate bona fides at last year’s American Society of Clinical Oncology (ASCO) conference, ...
FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases
FDA grants accelerated approval to AbbVie's Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes ...
US FDA approves AbbVie's drug for a type of lung cancer
The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...
Merck wins FDA label expansion for Welireg in neuroendocrine tumors
Merck (MRK) stock in focus as the FDA approves its anticancer agent Welireg for two rare neuroendocrine tumors, expanding its ...
Upheaval at FDA pushes some biotech firms to move early trials out of US
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
Orchestra BioMed Holdings - Breakthrough Device Designation Gives Speculative Optimism
Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is ...